Evaluation of the uric acid-to-HDL ratio in patients with type 2 diabetes mellitus and its association with renal prognosis
Main Article Content
Abstract
INTRODUCTION: Type 2 Diabetes Mellitus (T2DM) is a chronic metabolic disorder characterized by persistent hyperglycemia, commonly associated with obesity, physical inactivity, and unhealthy dietary patterns. Among its complications, Diabetic Kidney Disease (DKD) stands out due to its high prevalence and significant contribution to cardiovascular morbidity and mortality. Emerging biomarkers, such as serum uric acid (SUA) and its ratios with HDL cholesterol and creatinine, have been investigated as potential indicators of metabolic and renal risk. METHODS: This retrospective descriptive study analyzed secondary data from 1,232 patients with T2DM (HbA1c ≥7.0%), aged 40–70 years, of both sexes. Laboratory parameters included fasting glucose, HbA1c, creatinine, lipid profile, and SUA. The uric acid-to-HDL ratio (UHR) and uric acid-to-creatinine ratio (UCR) were calculated. Statistical analysis involved Spearman correlation and multiple linear regression models. RESULTS: Median HbA1c was 8.6%, with an estimated mean glucose of 200 mg/dL. Both UHR (ρ = -0.150; p < 0.001) and UCR (ρ = -0.202; p < 0.001) showed weak but significant inverse correlations with HbA1c. In adjusted models, HbA1c remained negatively associated with both ratios. Male sex was associated with higher UHR and lower UCR values. Age showed a negative association only with UCR. The regression models demonstrated limited explanatory power (R² < 0.10). DISCUSSION: The inverse relationship between glycemic control and the evaluated ratios suggests their potential as complementary metabolic markers. UCR demonstrated greater sensitivity to HbA1c variations and was influenced by age, whereas UHR appeared to be sex-dependent. These findings reinforce the complex interplay between glucose metabolism, lipid profile, and renal function in T2DM.
Downloads
Article Details

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC BY) that allows others to share and adapt the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.